Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. [electronic resource]
Producer: 20041026Description: 576S-599S p. digitalISSN:- 0012-3692
- Abciximab
- Angioplasty, Balloon, Coronary
- Antibodies, Monoclonal -- adverse effects
- Aspirin -- adverse effects
- Clopidogrel
- Contraindications
- Coronary Restenosis -- prevention & control
- Coronary Stenosis -- therapy
- Drug Therapy, Combination
- Evidence-Based Medicine
- Fibrinolytic Agents -- adverse effects
- Heparin -- adverse effects
- Hirudins -- adverse effects
- Humans
- Immunoglobulin Fab Fragments -- adverse effects
- Peptide Fragments -- adverse effects
- Practice Guidelines as Topic
- Pyridines -- adverse effects
- Recombinant Proteins -- adverse effects
- Risk Assessment
- Stents
- Ticlopidine -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Guideline; Journal Article; Practice Guideline; Review
There are no comments on this title.
Log in to your account to post a comment.